Estenne-Bouhtou; Genevieve

Patent Applications and Registrations

Patent applications and USPTO patent grants for Estenne-Bouhtou; Genevieve.The latest application filed is for "n-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof".

Company Profile

0.13.17

Estenne-Bouhtou; Genevieve - Chevilly-Larue N/A FR
Estenne-Bouhtou; Genevieve - Paris FR
Estenne-Bouhtou, Genevieve - Chevilly-Laure FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of N-heterocyclylmethylbenzamides in therapeutics Grant 8,513,246 - Dargazanli , et al. August 20, 2	2013-08-20
N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide Derivatives, Preparation Thereof, And Therapeutic Use Thereof App 20120071536 - Dargazanli; Gihad ; et al.	2012-03-22
N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide Derivatives, Preparation Thereof, And Therapeutic Use Of Same App 20120029027 - Estenne-Bouhtou; Genevieve ; et al.	2012-02-02
N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy Grant 7,951,821 - Dargazanli , et al. May 31, 2	2011-05-31
Derivatives Of Pyrrolizine, Indolizine And Quinolizine, Preparation Thereof And Therapeutic Use Thereof App 20100267766 - Dargazanli; Gihad ; et al.	2010-10-21
Derivatives Of N-phenyl(piperidine-2-yl) Methyl Benzamide Preparation Method Thereof And Applications Of Same In Therapeutics App 20100234424 - DARGAZANLI; Gihad ; et al.	2010-09-16
Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics Grant 7,790,753 - Dargazanli , et al. September 7, 2	2010-09-07
Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof Grant 7,776,880 - Dargazanli , et al. August 17, 2	2010-08-17
Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics Grant 7,750,025 - Dargazanli , et al. July 6, 2	2010-07-06
Derivatives of N-[phenyl(pyrrolidine-2-YL)methyl]benzamide and N-[(azepan-2-YL) phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics Grant 7,700,585 - Dargazanli , et al. April 20, 2	2010-04-20
Use Of N-heterocyclylmethylbenzamides In Therapeutics App 20100022548 - DARGAZANLI; Gihad ; et al.	2010-01-28
Derivatives of N-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics Grant 7,619,089 - Dargazanli , et al. November 17, 2	2009-11-17
Derivatives Of Pyrrolizine, Indolizine And Quinolizine, Preparation Thereof And Therapeutic Use Thereof App 20090258899 - DARGAZANLI; Gihad ; et al.	2009-10-15
Derivatives Of N-heterocyclylmethylbenzamides, Preparation Method Thereof And Application Of Same In Therapeutics App 20080070941 - DARGAZANLI; Gihad ; et al.	2008-03-20
Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics Grant 7,335,670 - Dargazanli , et al. February 26, 2	2008-02-26
N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy Grant 7,326,722 - Dargazanli , et al. February 5, 2	2008-02-05
Derivatives of N-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics Grant 7,288,656 - Dargazanli , et al. October 30, 2	2007-10-30
Derivatives Of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide And N-[(azepan-2-yl)phenylmethyl]benzamide, Preparation Method Thereof And Application Of Same In Therapeutics App 20070208006 - DARGAZANLI; Gihad ; et al.	2007-09-06
Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy App 20070197601 - DARGAZANLI; Gihad ; et al.	2007-08-23
N-[phenyl(piperidin-2-yl)methyl]benzamide Derivatives, Preparation Thereof, And Use Thereof In Therapy App 20070155789 - DARGAZANLI; Gihad ; et al.	2007-07-05
Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation, and use in treatment of schizophrenia Grant 7,226,917 - Dargazanli , et al. June 5, 2	2007-06-05
N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy Grant 7,205,319 - Dargazanli , et al. April 17, 2	2007-04-17
Derivatives of N-heterocyclylmethylbenzamides, prepartion method thereof and application of same in therapeutics App 20060264441 - Dargazanli; Gihad ; et al.	2006-11-23
Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics App 20060223885 - Dargazanli; Gihad ; et al.	2006-10-05
Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics App 20060223802 - Dargazanli; Gihad ; et al.	2006-10-05
Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics App 20060223861 - Dargazanli; Gihad ; et al.	2006-10-05
Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics App 20060223886 - Dargazanli; Gihad ; et al.	2006-10-05
Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics App 20050159450 - Dargazanli, Gihad ; et al.	2005-07-21
N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy App 20050153963 - Dargazanli, Gihad ; et al.	2005-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.